Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://zaynaberbk210665.bloginder.com/39682733/retaglutide-a-promising-glp-1-receptor-agonist